Impact of Posterior Cord Compression from Ligamentum Flavum on Clinical Outcomes Following ACDF or CDR

Andrea Pezzi1, Tomoyuki Asada1, Atahan Durbas1

  • 1Department of Spine Surgery, Hospital for Special Surgery, 535 E 70th St, New York, (NY), USA, 10021.

Spine
|December 6, 2025
PubMed

Insights

Hypertrophied ligamentum flavum (HLF) did not significantly impact outcomes after anterior cervical discectomy and fusion (ACDF) or cervical disc replacement (CDR). Both ACDF and CDR showed significant improvements in patient-reported outcomes.

Area of Science:

  • Spine surgery
  • Degenerative cervical spine disease
  • Cervical myelopathy

Background:

  • Hypertrophied ligamentum flavum (HLF) contributes to cervical myelopathy and spinal cord compression.
  • The impact of HLF on outcomes following anterior cervical discectomy and fusion (ACDF) is debated.
  • The role of cervical disc replacement (CDR) in patients with HLF is not well-defined.

Purpose of the Study:

  • To determine the impact of hypertrophied ligamentum flavum (HLF) on patient-reported outcomes after ACDF and CDR.
  • To compare the effectiveness of ACDF versus CDR in patients with HLF.

Main Methods:

  • Retrospective cohort study of 228 patients undergoing 1- or 2-level ACDF or CDR for cervical myelopathy/myeloradiculopathy.
  • HLF status was dichotomized (Non-HLF vs. HLF, with HLF further categorized as mild or severe).
  • Longitudinal outcomes assessed using Neck Disability Index (NDI), Numerical Rating Scale (NRS), and SF-12 PCS via multivariable linear mixed-effects models (LMMs), including IPTW-adjusted analyses.

Main Results:

  • Both ACDF and CDR groups showed significant improvements in NDI, NRS neck, and NRS arm over time.
  • HLF status did not significantly influence outcomes in either ACDF or CDR cohorts.
  • IPTW-adjusted comparisons in HLF patients revealed no significant difference in NDI trajectories between ACDF and CDR.

Conclusions:

  • HLF does not significantly affect outcomes following ACDF or CDR for cervical myelopathy/myeloradiculopathy.
  • CDR can be considered for carefully selected patients with mild HLF, offering significant improvements in patient-reported outcomes.
  • Findings challenge traditional views on excluding patients with HLF from CDR.
Abstract

Related Concept Videos